Cornerstone Capital Management Holdings’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-656	Closed	-$88K	–	1433
2016 Q3	$88K	Buy	656 +56	+9%	+$5.56K	﹤0.01%	1264
2016 Q2	$61K	Sell	600 -7,803	-93%	-$967K	﹤0.01%	1302
2016 Q1	$1.38M	Buy	8,403 +2,317	+38%	+$470K	0.01%	845
2015 Q4	$1.99M	Buy	6,086 +3,486	+134%	+$1.13M	0.02%	740
2015 Q3	$839K	Buy	2,600 +1,856	+249%	+$815K	0.01%	911
2015 Q2	$297K	Buy	744 +444	+148%	+$189K	﹤0.01%	1126
2015 Q1	$148K	Buy	+300	New	+$116K	﹤0.01%	1221

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Capital Management Holdings's LUMO Position: Q4 2016 in Review

Cornerstone Capital Management Holdings sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2016, closing a stake of 656 shares — an estimated $88K sold.

Cornerstone Capital Management Holdings first reported a position in LUMO in Q1 2015 and held it in 7 quarters. The position peaked at $1.99M in Q4 2015. 122 funds tracked by Wall St. Rank hold LUMO as of Q4 2016.

Cornerstone Capital Management Holdings reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 656 Lumos Pharma, Inc. Common Stock shares in Q4 2016, an estimated $88K.
Cornerstone Capital Management Holdings first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2015 and held it in 7 quarters.
Cornerstone Capital Management Holdings's Lumos Pharma, Inc. Common Stock position peaked at $1.99M in Q4 2015.
122 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.